Program Overview

Therapeutic & Regenerative Pipeline

"Leveraging the AGT platform to address pathology beyond oncology. We are validating specific 'Breaching Agents' for fibrotic and inflamed tissues."

The Revised Table (Strictly In-Vitro/Design Status)

Focus Area

Targeting the Tumor Microenvironment (TME).

"Developing 'Prime & Kill' strategies to disrupt the fibrotic matrix in high-grade gliomas, paving the way for advanced cell therapies."